Restoring FAS Expression via Lipid-Encapsulated FAS DNA Nanoparticle Delivery Is Sufficient to Suppress Colon Tumor Growth In Vivo.
Restoring FAS Expression via Lipid-Encapsulated FAS DNA Nanoparticle Delivery Is Sufficient to Suppress Colon Tumor Growth In Vivo.
复制标题
通过脂质包封的FAS DNA纳米颗粒递送恢复FAS表达足以抑制体内结肠肿瘤生长。
DOI:
10.3390/cancers14020361
复制
发表时间:
2022-01-12
期刊:
影响因子:
5.2
通讯作者:
Liu K
中科院分区:
文献类型:
--
作者:
Merting AD;Poschel DB;Lu C;Klement JD;Yang D;Li H;Shi H;Chapdelaine E;Montgomery M;Redman MT;Savage NM;Nayak-Kapoor A;Liu K
A key feature of human colorectal tumor is loss of FAS expression. FAS is the death receptor for FASL of activated T cells. Loss of FAS expression therefore may promote tumor cell immune escape. We aimed at determining whether restoring FAS expression is sufficient to suppress colorectal tumor growth. Mouse and human FAS cDNA was synthesized and encapsulated into cationic lipid nanoparticle DOTAP-Cholesterol to formulate DOTAP-Chol-mFAS and DOTAP-Chol-hFAS, respectively. Restoring FAS expression in metastatic mouse colon-tumor cells enabled FASL-induced elimination of FAS+ tumor cells in vitro and suppressed colon-tumor growth and progression in tumor-bearing mice in vivo. Restoring FAS expression induced FAS receptor auto-oligomerization and tumor cell auto-apoptosis in metastatic human colon-tumor cells in vitro. DOTAP-Chol-hFAS therapy is also sufficient to suppress metastatic human colon tumor xenograft growth in athymic mice. Tumor-selective delivery of FAS DNA nanoparticle is potentially an effective therapy for human colorectal cancer. A hallmark of human colorectal cancer is lost expression of FAS, the death receptor for FASL of cytotoxic T lymphocytes (CTLs). However, it is unknown whether restoring FAS expression alone is sufficient to suppress csolorectal-cancer development. The FAS promoter is hypermethylated and inversely correlated with FAS mRNA level in human colorectal carcinomas. Analysis of single-cell RNA-Seq datasets revealed that FAS is highly expressed in epithelial cells and immune cells but down-regulated in colon-tumor cells in human colorectal-cancer patients. Codon usage-optimized mouse and human FAS cDNA was designed, synthesized, and encapsulated into cationic lipid to formulate nanoparticle DOTAP-Chol-mFAS and DOTAP-Chol-hFAS, respectively. Overexpression of codon usage-optimized FAS in metastatic mouse colon-tumor cells enabled FASL-induced elimination of FAS+ tumor cells in vitro, suppressed colon tumor growth, and increased the survival of tumor-bearing mice in vivo. Overexpression of codon-optimized FAS-induced FAS receptor auto-oligomerization and tumor cell auto-apoptosis in metastatic human colon-tumor cells. DOTAP-Chol-hFAS therapy is also sufficient to suppress metastatic human colon tumor xenograft growth in athymic mice. DOTAP-Chol-mFAS therapy exhibited no significant liver toxicity. Our data determined that tumor-selective delivery of FAS DNA nanoparticles is sufficient for suppression of human colon tumor growth in vivo.
登录
查看更多内容
影响因子:
64.8
作者:
通讯作者:
--
影响因子:
4.2
作者:
Azwar S;Seow HF;Abdullah M;Faisal Jabar M;Mohtarrudin N
通讯作者:
Mohtarrudin N
影响因子:
20.3
作者:
Dufva, Olli;Koski, Jan;Mustjoki, Satu
通讯作者:
Mustjoki, Satu
影响因子:
4.8
作者:
Cremesti, A;Paris, F;Kolesnick, R
通讯作者:
Kolesnick, R
影响因子:
45.3
作者:
Kopetz, Scott;Chang, George J.;McWilliams, Robert R.
通讯作者:
McWilliams, Robert R.